SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-000781
Filing Date
2024-02-08
Accepted
2024-02-08 16:01:58
Documents
63
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR DEC 2023 sonoma_i10q-123123.htm   iXBRL 10-Q 763055
2 OFFER LETTER TO JEROME DVONCH sonoma_ex1041.htm EX-10.41 14699
3 OFFER LETTER TO JOHN DAL POGGETTO sonoma_ex1042.htm EX-10.42 15445
4 CERTIFICATION sonoma_ex3101.htm EX-31.1 8663
5 CERTIFICATON sonoma_ex3102.htm EX-31.2 8718
6 CERTIFICATION sonoma_ex3201.htm EX-32.1 4637
12 GRAPHIC image_001.jpg GRAPHIC 6748
  Complete submission text file 0001683168-24-000781.txt   3959417

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE snoa-20231231.xsd EX-101.SCH 28435
8 XBRL CALCULATION FILE snoa-20231231_cal.xml EX-101.CAL 47419
9 XBRL DEFINITION FILE snoa-20231231_def.xml EX-101.DEF 100860
10 XBRL LABEL FILE snoa-20231231_lab.xml EX-101.LAB 245795
11 XBRL PRESENTATION FILE snoa-20231231_pre.xml EX-101.PRE 201632
64 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-123123_htm.xml XML 544766
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 24608929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)